Association between PCV13 pneumococcal vaccination and risk of hospital admissions due to pneumonia or sepsis among patients with haematological malignancies: a single-centre retrospective cohort study in Israel

OBJECTIVES: Patients with haematological malignancies receiving immunosuppressive therapy are at highest risk of invasive pneumococcal disease. Our goal was to investigate whether vaccination of haematological patients with pneumococcal 13-valent conjugated vaccine (PCV13) prior to therapy initiatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Draliuk, Regina, Shadmi, Efrat, Preis, Meir, Dagan, Efrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013985/
https://www.ncbi.nlm.nih.gov/pubmed/35428637
http://dx.doi.org/10.1136/bmjopen-2021-056986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013985/
https://www.ncbi.nlm.nih.gov/pubmed/35428637
http://dx.doi.org/10.1136/bmjopen-2021-056986

Ejemplares similares